Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic β2 receptor in a Swedish hypertensive population

Abstract

The Arg16Gly and the Gln27Glu polymorphisms in the gene for the β2-adrenergic receptor (β2AR) have been linked to an increased risk for cardiovascular disease. The aim of the present study was to evaluate the significance of these haplotypes for development of myocardial infarction (MI) as well as other cardiovascular phenotypes. In a prospective study cohort (CAPPP), 522 hypertensive patients (174 MI and 348 matched controls) were analysed for the Arg16Gly and the Gln27Glu polymorphisms by dynamic allele-specific hybridisation. The haplotype could successfully be determined in 516 patients. Haplotype was not significantly associated with MI. Systolic blood pressure (SBP) was higher in patients with Arg16Gly+Gln27Gln and lower in patients with Arg16Gly+Gln27Glu as compared with the other haplotypes. Haplotype was not associated with body mass index, diastolic blood pressure, cholesterol, LDL, HDL triglycerides or a diagnosis of diabetes mellitus. The present study found no evidence that haplotype for the two most common polymorphisms in the β2AR are associated with development of MI in a Swedish hypertensive population, but haplotype may be associated with SBP.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Cockcroft JR et al. Beta2-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 2000; 36: 371–375.

    Article  CAS  Google Scholar 

  2. Small KM, McGraw DW, Liggett SB . Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 2003; 43: 381–411.

    Article  CAS  Google Scholar 

  3. Pereira AC et al. Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension 2003; 42: 685–692.

    Article  CAS  Google Scholar 

  4. Castellano M et al. Beta(2)-adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes. Hypertension 2003; 41: 361–367.

    Article  CAS  Google Scholar 

  5. Heckbert SR et al. Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 2003; 107: 2021–2024.

    Article  CAS  Google Scholar 

  6. Tomaszewski M et al. Essential hypertension and beta2-adrenergic receptor gene. Linkage and association analysis. Hypertension 2002; 40: 286–291.

    Article  CAS  Google Scholar 

  7. Hansson L et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional herapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353: 611–616.

    Article  CAS  Google Scholar 

  8. Mullis K et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol 1986; 51: 263–273.

    Article  CAS  Google Scholar 

  9. Howell WM, Jobs M, Gyllensten U, Brookes AJ . Dynamic allele-specific hybridization. A new method for scoring single nucleotide polymorphisms. Nat Biotechnol 1999; 17: 87–88.

    Article  CAS  Google Scholar 

  10. Yamada Y et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347: 1916–1923.

    Article  CAS  Google Scholar 

  11. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG . Genetic associations in large versus small studies: an empirical assessment. Lancet 2003; 361: 567–571.

    Article  Google Scholar 

Download references

Acknowledgements

The study was supported by grants from Sahlgrenska Academy (LUA), the Swedish Foundation for Strategic Research, the Sahlgrenska University Hospital Funds, the Swedish Research Council and the Swedish Society of Medicine. The authors are grateful to Lotta Uggla and Anna-Lena Jirestedt (Department of Clinical Pharmacology, Gothenburg, Sweden) for excellent technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S M Wallerstedt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wallerstedt, S., Eriksson, AL., Ohlsson, C. et al. Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic β2 receptor in a Swedish hypertensive population. J Hum Hypertens 19, 705–708 (2005). https://doi.org/10.1038/sj.jhh.1001897

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001897

Keywords

This article is cited by

Search

Quick links